Accessibility Statement

Depofarma S.p.a. (hereinafter referred to as “Depofarma”) is committed to making its website accessible, in accordance with Law No. 4 of January 9, 2004, and its subsequent amendments, implementing Directive (EU) 2016/2102 of the European Parliament and of the Council. This accessibility statement applies to the website depofarma.it.

Depofarma continues its efforts to constantly improve the accessibility of its website and services, driven by the belief that it is a collective moral obligation to ensure a seamless, accessible, and barrier-free experience for all users, including those with disabilities. Depofarma is committed to continuously monitoring accessibility issues, aiming to identify and resolve any potential barriers.

1. Compliance Status

This website is partially compliant with the requirements set out in Annex A of Legislative Decree 106/2018 (WCAG 2.1 Level AA), due to the non-compliances listed below.

Despite efforts to ensure digital accessibility, there may be limitations, especially when it comes to content owned or managed by third parties. In particular, Depofarma is not responsible for ensuring that third-party content, which may be present on or linked to this site, complies with WCAG criteria and other applicable regulations.

2. Non-accessible Content

The following content does not fully comply with the requirements set out in Appendix A of the UNI CEI EN 301549 standard due to the non-conformities listed below:
– Some visual content may contain generic and non-descriptive alt text.
– Some links are distinguished by the font and/or underlining and may therefore be ambiguous.
– In some areas, the contrast of colors is not sufficient.
– Text magnification and resizing text may cause minor layout issues.

Depofarma’s technical team is actively working to progressively resolve all identified non-compliances and any known accessibility issues.

3. Preparation of this Accessibility Statement

This statement was prepared on May 23, 2025, following an evaluation of the website to which it applies. The information contained in the statement was gathered using a combined assessment, including:
– Internal self-assessment conducted by Depofarma’s technical team.
– Automated analysis using accessibility verification tools (specifically: WAVE).

4. Feedback and Contact Information

To report accessibility issues or request information and content in an accessible format, please contact:
Depofarma S.p.a.
Registered Office: Via Terragliol 67 31022 Preganziol (TV), Italy
E-mail: info@depofarma.it

5. Response Procedure

Depofarma is committed to providing a response within 30 days of receiving a report, in accordance with current legislation.

6. Enforcement Procedure

In the case of an unsatisfactory response or no response within the specified timeframe, a complaint may be submitted to the Digital Ombudsman via the official website of AGID (Agency for Digital Italy) at: www.agid.gov.it.

7. Website Information

The website was published online on May 20, 2025, and undergoes periodic updates and modifications.
The site is built on the WordPress CMS platform.

8. Last Update of the Statement

June 1, 2025